Andrew D. Weinberg

13.0k total citations · 2 hit papers
145 papers, 9.5k citations indexed

About

Andrew D. Weinberg is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Andrew D. Weinberg has authored 145 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Immunology, 40 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Andrew D. Weinberg's work include Immunotherapy and Immune Responses (75 papers), Immune Cell Function and Interaction (64 papers) and T-cell and B-cell Immunology (64 papers). Andrew D. Weinberg is often cited by papers focused on Immunotherapy and Immune Responses (75 papers), Immune Cell Function and Interaction (64 papers) and T-cell and B-cell Immunology (64 papers). Andrew D. Weinberg collaborates with scholars based in United States, Slovakia and Japan. Andrew D. Weinberg's co-authors include Susan L. Swain, Gail E. Huston, M English, Michael Croft, William L. Redmond, Carl E. Ruby, Irene Gramaglia, Michael Lemon, Nigel Killeen and Rodney A. Prell and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Andrew D. Weinberg

141 papers receiving 9.3k citations

Hit Papers

IL-4 directs the developm... 1990 2026 2002 2014 1990 2018 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. Weinberg United States 51 7.2k 3.4k 1.1k 634 602 145 9.5k
Daniele D’Ambrosio Italy 40 6.2k 0.9× 2.8k 0.8× 1.6k 1.5× 1.2k 1.9× 781 1.3× 84 9.5k
Onur Boyman Switzerland 53 8.0k 1.1× 3.0k 0.9× 1.9k 1.8× 772 1.2× 841 1.4× 117 11.2k
Lynette A. Fouser United States 28 8.5k 1.2× 3.9k 1.1× 1.8k 1.8× 841 1.3× 911 1.5× 36 11.9k
Thomas A. Fleisher United States 53 5.6k 0.8× 1.8k 0.5× 1.4k 1.3× 411 0.6× 1.0k 1.7× 163 8.1k
Catharien M. U. Hilkens United Kingdom 45 5.4k 0.8× 1.2k 0.4× 1.2k 1.1× 803 1.3× 476 0.8× 100 7.7k
Makoto Miyara France 34 7.1k 1.0× 2.2k 0.6× 1.0k 1.0× 771 1.2× 821 1.4× 80 10.0k
Irma Joosten Netherlands 47 5.0k 0.7× 1.1k 0.3× 1.1k 1.0× 562 0.9× 713 1.2× 198 7.6k
Jonathan M. Green United States 43 6.3k 0.9× 1.7k 0.5× 1.6k 1.5× 426 0.7× 2.0k 3.4× 86 9.2k
Theresa L. Murphy United States 45 7.3k 1.0× 2.3k 0.7× 2.1k 2.0× 505 0.8× 1.3k 2.1× 68 10.2k
Andrea Doni Italy 52 7.0k 1.0× 1.7k 0.5× 2.5k 2.4× 379 0.6× 1.0k 1.7× 105 10.0k

Countries citing papers authored by Andrew D. Weinberg

Since Specialization
Citations

This map shows the geographic impact of Andrew D. Weinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Weinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Weinberg more than expected).

Fields of papers citing papers by Andrew D. Weinberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Weinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Weinberg. The network helps show where Andrew D. Weinberg may publish in the future.

Co-authorship network of co-authors of Andrew D. Weinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Weinberg. A scholar is included among the top collaborators of Andrew D. Weinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Weinberg. Andrew D. Weinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duhen, Rebekka, Carmen Ballesteros‐Merino, Alexandra K. Frye, et al.. (2021). Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells. Nature Communications. 12(1). 1047–1047. 114 indexed citations
2.
Polesso, Fanny, Andrew D. Weinberg, & Amy E. Moran. (2018). Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist. Cancer Immunology Research. 7(2). 269–281. 37 indexed citations
3.
Ruby, Carl E., Melissa A. Yates, Daniel Hirschhorn-Cymerman, et al.. (2009). Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right. The Journal of Immunology. 183(8). 4853–4857. 126 indexed citations
4.
Redmond, William L., Michael J. Gough, & Andrew D. Weinberg. (2009). Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T cell anergy in vivo (40.30). The Journal of Immunology. 182(Supplement_1). 40.30–40.30. 2 indexed citations
5.
Ruby, Carl E. & Andrew D. Weinberg. (2009). OX40-Enhanced Tumor Rejection and Effector T Cell Differentiation Decreases with Age. The Journal of Immunology. 182(3). 1481–1489. 35 indexed citations
6.
Gough, Michael J., et al.. (2008). OX40 Agonist Therapy Enhances CD8 Infiltration and Decreases Immune Suppression in the Tumor. Cancer Research. 68(13). 5206–5215. 139 indexed citations
7.
Redmond, William L. & Andrew D. Weinberg. (2007). Targeting OX40 and OX40L for the Treatment of Autoimmunity and Cancer. Critical Reviews in Immunology. 27(5). 415–436. 49 indexed citations
8.
Redmond, William L., Michael J. Gough, Bridget Charbonneau, Timothy L. Ratliff, & Andrew D. Weinberg. (2007). Defects in the Acquisition of CD8 T Cell Effector Function after Priming with Tumor or Soluble Antigen Can Be Overcome by the Addition of an OX40 Agonist. The Journal of Immunology. 179(11). 7244–7253. 72 indexed citations
9.
Weinberg, Andrew D., Colin Thalhofer, Joshua M. Walker, et al.. (2006). Anti-OX40 (CD134) Administration to Nonhuman Primates: Immunostimulatory Effects and Toxicokinetic Study. Journal of Immunotherapy. 29(6). 575–585. 39 indexed citations
10.
Maxwell, Joseph R., Rajwardhan Yadav, Robert J. Rossi, et al.. (2006). IL-18 Bridges Innate and Adaptive Immunity through IFN-γ and the CD134 Pathway. The Journal of Immunology. 177(1). 234–245. 82 indexed citations
11.
Chou, Yuan K., Andrew D. Weinberg, Arthur A. Vandenbark, et al.. (2005). Activation Pathways Implicate Anti-HLA-DP and Anti-LFA-1 Antibodies as Lead Candidates for Intervention in Chronic Berylliosis. The Journal of Immunology. 174(7). 4316–4324. 15 indexed citations
12.
Lathrop, Stephanie K., et al.. (2004). A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions. The Journal of Immunology. 172(11). 6735–6743. 75 indexed citations
13.
Weinberg, Andrew D., et al.. (2003). Quality Improvement Case Study: Issues Involving Elopment of Residents. Journal of the American Medical Directors Association. 4(2). S76–S77. 2 indexed citations
14.
Maxwell, Joseph R., et al.. (2001). OX40 Ligation Enhances Cell Cycle Turnover of Ag-Activated CD4 T Cells in Vivo. Cellular Immunology. 209(1). 63–75. 28 indexed citations
15.
Kjaergäard, Jørgen, Liaomin Peng, Peter A. Cohen, et al.. (2001). Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor. The Journal of Immunology. 167(11). 6669–6677. 61 indexed citations
16.
Evans, Dean E., Rodney A. Prell, Colin Thalhofer, Arthur A. Hurwitz, & Andrew D. Weinberg. (2001). Engagement of OX40 Enhances Antigen-Specific CD4+ T Cell Mobilization/Memory Development and Humoral Immunity: Comparison of αOX-40 with αCTLA-4. The Journal of Immunology. 167(12). 6804–6811. 82 indexed citations
17.
Weinberg, Andrew D., Rodney A. Prell, Arden M. Morris, et al.. (2000). Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity. The Journal of Immunology. 164(4). 2160–2169. 315 indexed citations
18.
Maxwell, Joseph R., Andrew D. Weinberg, Rodney A. Prell, & Anthony T. Vella. (2000). Danger and OX40 Receptor Signaling Synergize to Enhance Memory T Cell Survival by Inhibiting Peripheral Deletion. The Journal of Immunology. 164(1). 107–112. 188 indexed citations
19.
Gramaglia, Irene, et al.. (2000). The OX40 Costimulatory Receptor Determines the Development of CD4 Memory by Regulating Primary Clonal Expansion. The Journal of Immunology. 165(6). 3043–3050. 322 indexed citations
20.
Weinberg, Andrew D., et al.. (1997). The utilization of intravenous therapy programs in community long-term care nursing facilities.. PubMed. 1(3). 161–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026